Complexity in endometrial estradiol signaling

Reproductive Sciences

Volumn 14, Issue 7, 2007, Pages 627-628

  Young, Steven L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; CALCIUM; CYCLIC AMP; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; TAMOXIFEN;

BINDING SITE; BREAST CANCER; DNA MICROARRAY; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION REGULATION; HUMAN; PRIORITY JOURNAL; SECOND MESSENGER; SHORT SURVEY; SIGNAL TRANSDUCTION; ARTICLE; DRUG EFFECT; METABOLISM;

ENDOMETRIUM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; SIGNAL TRANSDUCTION; TAMOXIFEN;

EID: 38449107964     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719107309062     Document Type: Short Survey

References (13)

1. Ismail SM Gynaecological effects of tamoxifen. J Clin Pathol. 1999 ; 52 (2). 83-88.
2. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG committee opinion. No. 336: tamoxifen and uterine cancer. Obstet Gynecol. 2006 ; 107 (6). 1475-1478.
3. Kuiper GG, Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson JA Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996 ; 93 (12). 5925-5930.
4. Moriarty K., Kim KH, Bender JR Minireview: estrogen receptor-mediated rapid signaling. Endocrinology. 2006 ; 147 (12). 5557-5563.
5. Treeck O., Pfeiler G., Horn F., et al. Novel estrogen receptor beta transcript variants identified in human breast cancer cells affect cell growth and apoptosis of COS-1 cells. Mol Cell Endocrinol. 2007 ; 264 (1-2). 50-60.
6. Gururaj AE, Rayala SK, Vadlamudi RK, Kumar R. Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations. Clin Cancer Res. 2006 12 (3 pt 2). 1001s - 1007s.
7. Popov VM, Wang C., Shirley LA, et al. The functional significance of nuclear receptor acetylation. Steroids. 2007 ; 72 (2). 221-230.
8. Kazi AA, Jones JM, Koos RD Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Mol Endocrinol. 2005 ; 19 (8). 2006-2019.
9. Jensen EV, DeSombre ER Estrogen-receptor interaction. Science. 1973 ; 182 (108). 126-134.
10. Pietras RJ, Szego CM Endometrial cell calcium and oestrogen action. Nature. 1975 ; 253 (5490). 357-359.
11. Nabekura J., Oomura Y., Minami T., Mizuno Y., Fukuda A. Mechanism of the rapid effect of 17 beta-estradiol on medial amygdala neurons. Science. 1986 ; 233 (4760). 226-228.
12. Warner M., Gustafsson JA Nongenomic effects of estrogen: why all the uncertainty? Steroids. 2006 ; 71 (2). 91-95.
13. Guzeloglu Kayisli O, Kayisli UA, Luleci G., Arici A. In vivo and in vitro regulation of Akt activation in human endometrial cells is estrogen dependent. Biol Reprod. 2004 ; 71 (3). 714-721.